 | | DRUG: Influenza virus vaccine | |
Entry |
|
Name |
Influenza virus vaccine (USP); FluShield (TN); Fluarix quadrivalent (TN) |
Product |
AFLURIA (Seqirus PTY), FLUAD (Seqirus), FLUARIX (GlaxoSmithKline Biologicals SA), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Sanofi Pasteur), FLUBLOK TRIVALENT NORTHERN HEMISPHERE (Sanofi Pasteur), FLUCELVAX (Seqirus), FLULAVAL (ID Biomedical Corporation of Quebec), FLUZONE HIGH DOSE NORTHERN HEMISPHERE (Sanofi Pasteur), FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Bamboo US BidCo LLC), FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Sanofi Pasteur), FLUZONE TRIVALENT (Bamboo US BidCo LLC), FLUZONE TRIVALENT NORTHERN HEMISPHERE (Sanofi Pasteur) |
Remark |
Product (DG00674): | D04536<US> D05182<JP> |
|
Efficacy |
Active immunization (influenza virus) |
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07B VIRAL VACCINES
J07BB Influenza vaccines
J07BB01 Influenza, inactivated, whole virus
D04536 Influenza virus vaccine (USP) <US>
|
Other DBs |
|
LinkDB |
|
|
» Japanese version » Back
|